https://www.miragenews.com/protein-levels-fuel-tumor-immune-suppression-in-1598714/
A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune response in five preclinical
immune suppressionproteinlevelsfueltumor
https://pubmed.ncbi.nlm.nih.gov/41538362/
Epidermal growth factor receptor (EGFR)-activating mutations are established biomarkers of resistance to immune checkpoint blockade (ICB) in lung cancer, yet...
egfractivationimmunotherapyresponsevia
https://www.sciencedaily.com/releases/2009/03/090317153041.htm
One of the small regulatory molecules, named microRNA-125b, is a novel regulator of p53, an important protein that safeguards cells against cancers, scientists...
regulatorymoleculetumorformationsuppression
https://curie.fr/publications/pla2r1-mediates-tumor-suppression-activating-jak2
Abstract Little is known about the physiological role of the phospholipase A2 receptor (PLA2R1). PLA2R1 has been described as regulating the replicative...
tumor suppressioninstitut curiemediatesactivating
https://pubmed.ncbi.nlm.nih.gov/31123083/
Classical antagonistic antibodies (Abs) targeting PD-1, such as pembrolizumab and nivolumab, act through blockade of the PD-1-PDL-1 interaction. Here, we have...
tumor suppressionnovelantipdmediated